HIV and Tuberculosis: a Deadly Human Syndemic
Open accessThe DOI matches its Crossref record; 270 of the 271 references it cites were found in a registry or an index.
Abstract
SUMMARY: A syndemic is defined as the convergence of two or more diseases that act synergistically to magnify the burden of disease. The intersection and syndemic interaction between the human immunodeficiency virus (HIV) and tuberculosis (TB) epidemics have had deadly consequences around the world. Without adequate control of the TB-HIV syndemic, the long-term TB elimination target set for 2050 will not be reached. There is an urgent need for additional resources and novel approaches for the diagnosis, treatment, and prevention of both HIV and TB. Moreover, multidisciplinary approaches that consider HIV and TB together, rather than as separate problems and diseases, will be necessary to prevent further worsening of the HIV-TB syndemic. This review examines current knowledge of the state and impact of the HIV-TB syndemic and reviews the epidemiological, clinical, cellular, and molecular interactions between HIV and TB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Originally focused on vulnerable communities in high-income countries (HICs) [ 1 ], more recently, a syndemics approach has been applied in low- and middle-income countries (LMICs) [ 13–15 ].”
From Syndemic contexts: findings from a review of research on non-communicable diseases and interviews with experts (2021) · cites this paper as [14]
In the citing paper
“Studies show that HIV co-infection, which increases the risk of latent TB reactivation 20-fold, is the most powerful known risk factor for the progression of Mycobacterium tuberculosis infection to an active disease [16,17].”
From Treatment success rate of tuberculosis patients in Dabat, northwest Ethiopia (2014) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553 · cited 2×
“The confluence of the two epidemics has hit hardest in sub-Saharan Africa, which constituted 79% of all cases of incident TB in persons with HIV infection in 2007 (62, 263).”
BackgroundAn essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465 · cited 19×
“Ironically, the fifth subject, for whom the frequency of M. tuberculosis antigen-responsive IFN- -producing cells did not decline, developed active TB, which was accompanied by an increased frequency of M. tuberculosis antigenresponsive IFN- -producing CD4 memory cells.”
ResultInfluentialRapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 4×
“In South African study populations with HIV prevalence rates of 71 to 76%, Xpert MTB/RIF testing of three sputum samples (one direct and two concentrated) has a sensitivity of greater than 95% for all culture-positive TB cases, with 99 to 100% sensitivity for smear-positive, culture-positive TB; 87 to 90% sensitivity…”
BackgroundMethodInfluentialAn inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,041 · cited 1×
“TLR2, TLR4, NOD2, and TNF all signal through the host transcription factor NF- B (179), which directly activates the transcription of HIV (79, 201, 205).”
BackgroundDisseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986 · cited 19×
“Ironically, the fifth subject, for whom the frequency of M. tuberculosis antigen-responsive IFN- -producing cells did not decline, developed active TB, which was accompanied by an increased frequency of M. tuberculosis antigenresponsive IFN- -producing CD4 memory cells.”
ResultInfluentialGandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732 · cited 28×
“The use of NVP with rifampin was associated with higher rates of virologic failure starting at 6 months after the initiation of treatment in a South African prospective cohort study (29).”
BackgroundInfluentialOsborn, L., Kunkel, S., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,621 · cited 1×
“TLR2, TLR4, NOD2, and TNF all signal through the host transcription factor NF- B (179), which directly activates the transcription of HIV (79, 201, 205).”
BackgroundSelwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574 · cited 2×
“A prospective study of injection drug users (IDUs) enrolled in a methadone maintenance program in New York City found that active TB developed in 7 of 49 HIV-infected subjects with a prior positive purified protein derivative (PPD) test and in none of 62 HIV-uninfected subjects with a prior positive PPD test (227).”
BackgroundTuberculosis in Patients with Human Immunodeficiency Virus Infection
Havlir, D. V., & Barnes, P. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400507 · Cited by 1,461 · cited 6×
“Evidence that HIV serves as a driver of TB at the population level has been noted by multiple epidemiological studies (15, 20).”
BackgroundInfluentialTsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding
Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. H., Wang, H. E., Wettstein, D. A., Stray, K. M., Côté, M., Rich, R. L., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00506-2 · Cited by 1,369 · cited 1×
“Since HIV is known to utilize tsg101 in the process of viral budding (106), it is reasonable to hypothesize that HIV may divert tsg101 and the ESCRT apparatus from mycobacterial phagosomes and thereby promote the intracellular survival and replication of M.”
BackgroundKaplan, J. E., Benson, C., Holmes, K. K., Brooks, J. T., Pau, A., & Masur, H. (2009) · PsycEXTRA Dataset · doi:10.1037/e537722009-001 · Cited by 1,343
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Drivers of tuberculosis epidemics: The role of risk factors and social determinants
Lönnroth, K., Jaramillo, E., Williams, B. G., Dye, C., & Raviglione, M. (2009) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.03.041 · Cited by 1,176 · cited 1×
“The association between poverty, urbanization, housing density, and TB incidence is well documented (27, 50, 164, 207).”
BackgroundImpaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., et al. (2008) · Nature · doi:10.1038/nature06764 · Cited by 1,157
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
Matloubian, M., Concepcion, R. J., & Ahmed, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8056-8063.1994 · Cited by 1,157 · cited 1×
“T cells (176), and in humans with HIV, the number of CD8 T”
BackgroundMehandru, S., Poles, M. A., Tenner-Racz, K., Horowitz, A., Hurley, A., Hogan, C., Boden, D., Racz, P., & Markowitz, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041196 · Cited by 1,146 · cited 1×
“The best-characterized and most important effect of HIV on immunity to TB and other infections is the depletion of CD4 T cells from secondary lymphoid tissues, peripheral blood, and mucosal sites such as the intestinal lamina propria (118, 180).”
BackgroundMazurek, G. H., Jereb, J., Vernon, A. A., LoBue, P. A., GOLDBERG, S. V., & Castro, K. G. (2010) · PubMed · Cited by 1,131
An Antimicrobial Activity of Cytolytic T Cells Mediated by Granulysin
Stenger, S., Hanson, D. A., Teitelbaum, R., Dewan, P., Niazi, K. R., Froelich, C. J., Ganz, T., Thoma-Uszynski, S., Melián, A., Bogdan, C., et al. (1998) · Science · doi:10.1126/science.282.5386.121 · Cited by 1,065
Daley, C. L., Small, P. M., Schecter, G. F., Schoolnik, G. K., McAdam, R. A., Jacobs, W. R., & Hopewell, P. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260404 · Cited by 986 · cited 1×
“tuberculosis, 73% (11 of 15) developed active TB within the first 6 months of TB infection (67).”
BackgroundM. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells
van der Wel, N., Hava, D., Houben, D., Fluitsma, D., van Zon, M., Pierson, J., Brenner, M., & Peters, P. J. (2007) · Cell · doi:10.1016/j.cell.2007.05.059 · Cited by 960 · cited 1×
“tuberculosis, most (200) but not all (252) of the bacteria reside in membrane-bound phagosomes, which, through a vesicular pathway, deliver peptide antigens bound to HLA class II molecules to the cell surface.”
BackgroundTuberculosis control and elimination 2010–50: cure, care, and social development
Lönnroth, K., Castro, K. G., Chakaya, J. M., Chauhan, L. S., Floyd, K., Glaziou, P., & Raviglione, M. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60483-7 · Cited by 899 · cited 1×
“Without an adequate control of the TB-HIV syndemic, the long-term TB elimination target set for 2050 will not be reached (163).”
BackgroundTuberculosis in Patients with Human Immunodeficiency Virus Infection
Barnes, P. F., Bloch, A. B., Davidson, P. T., & Snider, D. E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106063242307 · Cited by 862
Aberg, J. A., Kaplan, J. E., Libman, H., Emmanuel, P., Anderson, J. R., Stone, V. E., Oleske, J. M., Currier, J. S., & Gallant, J. E. (2009) · Clinical Infectious Diseases · doi:10.1086/605292 · Cited by 837 · cited 1×
“guidelines recommend that all persons should be tested for latent TB infection (LTBI) with either a tuberculin skin test (TST) or gamma interferon (IFN- ) release assays (IGRAs) at the time of HIV diagnosis (4, 142).”
BackgroundHuman Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis
Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3920 · Cited by 804 · cited 3×
“TLR2, TLR4, NOD2, and TNF all signal through the host transcription factor NF- B (179), which directly activates the transcription of HIV (79, 201, 205).”
BackgroundA Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Glocker, E.-O., Hennigs, A., Nabavi, M., Schäffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810719 · Cited by 800 · cited 1×
“Th17 cells recognize bacterial and fungal (and, less commonly, viral) antigens, secrete IL-17 and IL-22, and contribute to immunity to yeasts, extracellular bacteria (114, 166, 190), and, possibly, M.”
BackgroundDuh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S., & Rabson, A. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5974 · Cited by 767 · cited 1×
“TLR2, TLR4, NOD2, and TNF all signal through the host transcription factor NF- B (179), which directly activates the transcription of HIV (79, 201, 205).”
BackgroundMeintjes, G., Lawn, S. D., Scano, F., Maartens, G., French, M. A., Worodria, W., Elliott, J. H., Murdoch, D., Wilkinson, R. J., Seyler, C., et al. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70184-1 · Cited by 745 · cited 2×
“For unmasking TB-IRIS, the INSHI proposed the following provisional definition: a patient not receiving TB treatment when ART is initiated who then presents with active TB within 3 months of ART initiation and who has either a heightened intensity of clinical manifestations, particularly if there is evidence of a mark…”
BackgroundMethodEpidemiology of Extrapulmonary Tuberculosis in the United States, 1993–2006
Peto, H. M., Pratt, R. H., Harrington, T. A., LoBue, P. A., & Armstrong, L. R. (2009) · Clinical Infectious Diseases · doi:10.1086/605559 · Cited by 741 · cited 1×
“Unlike persons without HIV, in whom extrapulmonary TB is usually found in the absence of pulmonary TB, HIVinfected persons with extrapulmonary TB are more likely to have concomitant pulmonary TB (15, 212, 229, 255).”
BackgroundThe state of the world population 2007: unleashing the potential of urban growth.
Lahariya, C. (2008) · PubMed · Cited by 703
Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E., & Trono, D. (1994) · Cell · doi:10.1016/0092-8674(94)90360-3 · Cited by 695 · cited 1×
“cytosis of CD4 molecules at the cell surface (10).”
BackgroundFrieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., & Dye, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14333-4 · Cited by 689
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Abdool Karim, S. S., Naidoo, K., Grobler, A., Padayatchi, N., Baxter, C., Gray, A., Gengiah, T., Nair, G., Bamber, S., Singh, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905848 · Cited by 666 · cited 24×
“Clinical criteria are defined as the onset of TB-IRIS manifestations within 3 months of ART initiation, reinitiation, or regimen change because of treatment failure.”
BackgroundMethodInfluentialDeficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3
Ma, C. S., Chew, G. Y. J., Simpson, N., Priyadarshi, A., Wong, M., Grimbacher, B., Fulcher, D. A., Tangye, S. G., & Cook, M. C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080218 · Cited by 652 · cited 1×
“Th17 cells recognize bacterial and fungal (and, less commonly, viral) antigens, secrete IL-17 and IL-22, and contribute to immunity to yeasts, extracellular bacteria (114, 166, 190), and, possibly, M.”
BackgroundImmune restoration disease after antiretroviral therapy
French, M. A., Price, P., & Stone, S. F. (2004) · AIDS · doi:10.1097/01.aids.0000131375.21070.06 · Cited by 651 · cited 1×
“infiltrates or pleural effusions, hepatosplenomegaly, or ascites (54, 96, 123, 142, 182).”
BackgroundDifferential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections
Brenchley, J. M., Paiardini, M., Knox, K. S., Asher, A. I., Cervasi, B., Asher, T. E., Scheinberg, P., Price, D. A., Hage, C. A., Kholi, L. M., et al. (2008) · Blood · doi:10.1182/blood-2008-05-159301 · Cited by 648 · cited 1×
“During the early stages of HIV infection, the CD4 T cell population in the intestinal lamina propria is depleted preferentially and markedly; a large fraction of the cells lost in this initial phase of infection are CD4 Th17 effector memory cells (31).”
BackgroundPriorities for the Treatment of Latent Tuberculosis Infection in the United States
Horsburgh, C. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmsa031667 · Cited by 644 · cited 1×
“In contrast, this risk is approximately 10% per year for HIV-infected persons (128, 142, 227, 228).”
BackgroundDC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells
Tailleux, L., Schwartz, O., Herrmann, J.-L., Pivert, E., Jackson, M., Amara, A., Legres, L., Dreher, D., Nicod, L. P., Gluckman, J. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021468 · Cited by 643 · cited 1×
“tuberculosis resides in macrophages has been known at least since the studies of Sabin and colleagues in the 1920s (65, 220), although the spectrum of cells in which the bacteria reside in vivo has been recently found to include myeloid dendritic cells (129, 244, 269).”
ResultTuberculosis in New York City — Turning the Tide
Frieden, T. R., Fujiwara, P. I., Washko, R. M., & Hamburg, M. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330406 · Cited by 640 · cited 1×
“That hospitals and prisons with poor or inconsistent infection control practices can serve as locations for the spread of TB to persons infected with HIV was documented in the early 1990s in New York and Florida (38, 41, 43, 97, 98).”
BackgroundClerici, M., Stocks, N. I., Zajac, R. A., Boswell, R. N., Lucey, D. R., Via, C. S., & Shearer, G. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114376 · Cited by 613 · cited 1×
“An early study characterized functional responses (assayed as IL-2 production) of peripheral blood T cells from HIV-infected patients with CD4 T cell counts of 400/ l and described a time-dependent progression of defective responses, with a loss of responses to foreign recall antigens (influenza virus and tetanus toxo…”
BackgroundThe Population Dynamics and Control of Tuberculosis
Dye, C., & Williams, B. G. (2010) · Science · doi:10.1126/science.1185449 · Cited by 604 · cited 3×
“The transmission of TB is a product of the infectiousness of the index case and the duration of infectiousness (80), both of which can be affected by HIV.”
BackgroundInfluentialHIV Infection–Associated Tuberculosis: The Epidemiology and the Response
Getahun, H., Gunneberg, C., Granich, R., & Nunn, P. (2010) · Clinical Infectious Diseases · doi:10.1086/651492 · Cited by 598 · cited 1×
“4 million people living with HIV in 2008, nearly 30% were estimated to have latent or active TB infection (111, 249, 250, 262).”
BackgroundDirectly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
Hellerstein, M., Hanley, M. B., Cesar, D., Siler, S., Papageorgopoulos, C., Wieder, E., Schmidt, D., Hoh, R., Neese, R., Macallan, D., et al. (1999) · Nature Medicine · doi:10.1038/4772 · Cited by 593 · cited 1×
“In addition to increased CD4 T cell death induced by HIV, a decreased thymic output of naïve CD4 T cells in HIV-infected subjects results in an inability to replace CD4 T cells at the rate that they are destroyed (125, 126).”
BackgroundTargeting early infection to prevent HIV-1 mucosal transmission
Haase, A. T. (2010) · Nature · doi:10.1038/nature08757 · Cited by 593 · cited 1×
“Since recent studies of the early stages of HIV infection have revealed that the local recruitment of CD4 T cells accelerates the early spread and progression of HIV (118, 119), it is also possible VOL.”
BackgroundJones, B. E., Young, S. M. M., Antoniskis, D., Davidson, P. T., Kramer, F., & Barnes, P. F. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1292 · Cited by 586 · cited 1×
“Although pulmonary TB is the most common presentation regardless of the stage of HIV infection, persons with advanced immune suppression are more likely to have extrapulmonary TB than are HIV-infected persons with relatively intact immunity or persons without HIV (15, 33, 83, 136).”
BackgroundSteingart, K. R., Ng, V., Henry, M., Hopewell, P. C., Ramsay, A., Cunningham, J., Urbanczik, R., Perkins, M. D., Aziz, M. A., & Pai, M. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70602-8 · Cited by 573 · cited 1×
“Due to operator dependence on sample collection and processing and interpretation of sputum smears, the sensitivity of the sputum smear ranges from 20% to 60% in resource-constrained settings (37, 217, 236).”
BackgroundMogues, T., Goodrich, M. E., Ryan, L., LaCourse, R., & North, R. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.271 · Cited by 558 · cited 2×
“tuberculosis-infected immunocompetent mice (194).”
BackgroundWolf, A. J., Linas, B., Trevejo-Nuñez, G. J., Kincaid, E., Tamura, T., Takatsu, K., & Ernst, J. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2509 · Cited by 557 · cited 1×
“tuberculosis resides in macrophages has been known at least since the studies of Sabin and colleagues in the 1920s (65, 220), although the spectrum of cells in which the bacteria reside in vivo has been recently found to include myeloid dendritic cells (129, 244, 269).”
ResultSelf-citationBadri, M., Wilson, D., & Wood, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08904-3 · Cited by 556 · cited 1×
“The use of ART and immunological recovery, a rise in CD4 counts, significantly decreased the incidence of TB, with the greatest effect on patients with restored CD4 cell counts above 500 cells/ l (14, 113, 151, 156, 223).”
MethodIL-21 Is Required to Control Chronic Viral Infection
Elsaesser, H., Sauer, K., & Brooks, D. G. (2009) · Science · doi:10.1126/science.1174182 · Cited by 554
Haase, A. T. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.625 · Cited by 548 · cited 2×
“Since recent studies of the early stages of HIV infection have revealed that the local recruitment of CD4 T cells accelerates the early spread and progression of HIV (118, 119), it is also possible VOL.”
BackgroundKarim, S. S. A., Churchyard, G. J., Karim, Q. A., & Lawn, S. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60916-8 · Cited by 545 · cited 1×
“South African migrant workers who lived in overcrowded hostels and had sex with commercial sex workers were at a high risk of acquiring and transmitting HIV and TB in the cities where they worked, and they subsequently transmitted the infections to their wives and families during regular visits back to their hometowns…”
BackgroundLawn, S. D., Bekker, L.-G., & Miller, R. F. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70140-7 · Cited by 545 · cited 1×
“Incidence rates of paradoxical TB-IRIS range from 8% to 43%, and the majority of TB-IRIS occurs within the first 4 to 8 weeks after the initiation of ART (54, 73, 152, 182).”
BackgroundAccelerated course of human immunodeficiency virus infection after tuberculosis.
Whalen, C., Horsburgh, C. R., Hom, D., Lahart, C., Simberkoff, M., & Ellner, J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.1.7812542 · Cited by 535 · cited 2×
“Preliminary data from observational and retrospective studies have suggested that TB accelerates the progression of disease in HIV (13, 168, 259).”
Background[Epidemiology of tuberculosis].
Neumann, G. (1971) · PubMed · Cited by 523
Differential Effects of Cytolytic T Cell Subsets on Intracellular Infection
Stenger, S., Mazzaccaro, R. J., Uyemura, K., Cho, S., Barnes, P. F., Rosat, J.-P., Sette, A., Brenner, M. B., Porcelli, S. A., Bloom, B. R., et al. (1997) · Science · doi:10.1126/science.276.5319.1684 · Cited by 519 · cited 1×
“in vitro (49, 137, 238) and contribute to the killing of mycobac-”
BackgroundA Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection
Yi, J. S., Du, M., & Zajac, A. J. (2009) · Science · doi:10.1126/science.1175194 · Cited by 504
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
Goletti, D., Weissman, D., Jackson, R. W., Graham, N. M., Vlahov, D., Klein, R. S., Munsiff, S. S., Ortona, L., Cauda, R., & Fauci, A. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1271 · Cited by 495
Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB
Moore, D. A. J., Evans, C. A. W., Gilman, R. H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Piñedo, Y., Saravia, J. C., Salazar, C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055524 · Cited by 468
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
Wallis, R. S., Pai, M., Menzies, D., Doherty, T. M., Walzl, G., Perkins, M. D., & Zumla, A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60359-5 · Cited by 453
Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue
Doitsh, G., Cavrois, M., Lassen, K. G., Zepeda, O., Yang, Z., Santiago, M. L., Hebbeler, A. M., & Greene, W. C. (2010) · Cell · doi:10.1016/j.cell.2010.11.001 · Cited by 452 · cited 1×
“These in vitro studies provide a molecular mechanism for the profound depletion of abortively infected CD4 T cells as well as a mechanism for an accompanying inflammatory response that may contribute further to the manifestations of HIV infection (78).”
IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection
Fröhlich, A., Kisielow, J., Schmitz, I., Freigang, S., Shamshiev, A. T., Weber, J., Marsland, B. J., Oxenius, A., & Kopf, M. (2009) · Science · doi:10.1126/science.1172815 · Cited by 450
EPIDEMIOLOGY OF TUBERCULOSIS IN THE UNITED STATES
RIEDER, H. L., CAUTHEN, G. M., COMSTOCK, G. W., & SNIDER, D. E. (1989) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036046 · Cited by 447
Sonnenberg, P., Glynn, J. R., Fielding, K., Murray, J., Godfrey‐Faussett, P., & Shearer, S. (2005) · The Journal of Infectious Diseases · doi:10.1086/426827 · Cited by 446 · cited 2×
“Since TB occurs with an increased incidence early after HIV infection, prior to a measurable depletion of CD4 T cells from peripheral blood (234), there is substantial interest in determining whether HIV infection disproportionately depletes M.”
BackgroundCorbett, E. L., Marston, B., Churchyard, G. J., & De Cock, K. M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68383-9 · Cited by 438 · cited 1×
“The transmission of TB from HIV-uninfected TB cases, who are more likely to have smear-positive and cavitary pulmonary TB and a longer duration of infectiousness, to susceptible HIV-infected individuals clearly serves as a major driving force for the HIV-TB syndemic (61).”
BackgroundSonnenberg, P., Murray, J., Glynn, J. R., Shearer, S., Kambashi, B., & Godfrey-Faussett, P. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06712-5 · Cited by 433 · cited 1×
“DNA fingerprinting of another cohort of South African mine workers with recurrent TB found that HIV infection was a risk factor for recurrent TB due to reinfection but not relapse (235).”
BackgroundNatural Ventilation for the Prevention of Airborne Contagion
Escombe, A. R., Oeser, C. C., Gilman, R. H., Navincopa, M., Ticona, E., Pan, W., Martínez, C., Chacaltana, J., Rodríguez, R., Moore, D. A. J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040068 · Cited by 420 · cited 2×
“However, respiratory masks may not be used in a timely fashion due to delayed diagnosis, and negative-pressure ventilation rooms may not be adequately maintained, even if available (88, 268).”
BackgroundScriba, T. J., Kalsdorf, B., Abrahams, D.-A., Isaacs, F., Hofmeister, J., Black, G., Hassan, H. Y., Wilkinson, R. J., Walzl, G., Gelderbloem, S. J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1962 · Cited by 410
T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock
Hazenberg, M. D., Hamann, D., Schuitemaker, H., & Miedema, F. (2000) · Nature Immunology · doi:10.1038/79724 · Cited by 383
Jouanguy, E., Lamhamedi-Cherradi, S., Altare, F., Fondanèche, M. C., Tuerlinckx, D., Blanche, S., Emile, J. F., Gaillard, J. L., Schreiber, R., Levin, M., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119810 · Cited by 377 · cited 1×
“bovis BCG, have revealed mutations in the gene encoding a subunit of the IFN- receptor (139), and further studies have revealed IFNreceptor mutations in certain HIV-negative patients with severe and/or recurrent TB (139, 140).”
BackgroundNOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis
Ferwerda, G., Girardin, S. E., Kullberg, B.-J., Le Bourhis, L., de Jong, D. J., Langenberg, D. M. L., van Crevel, R., Adema, G. J., Ottenhoff, T. H. M., Van der Meer, J. W. M., et al. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010034 · Cited by 365
Lawn, S. D., Badri, M., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000194808.20035.c1 · Cited by 352 · cited 1×
“The use of ART and immunological recovery, a rise in CD4 counts, significantly decreased the incidence of TB, with the greatest effect on patients with restored CD4 cell counts above 500 cells/ l (14, 113, 151, 156, 223).”
MethodLawn, S. D., Myer, L., Edwards, D., Bekker, L.-G., & Wood, R. (2009) · AIDS · doi:10.1097/qad.0b013e32832d3b6d · Cited by 338 · cited 4×
“However, despite ART treatment, the overall TB incidence rate for HIV-infected patients still remained approximately 10-fold higher than that for adults without HIV (156).”
BackgroundMethodInfluentialCough-generated Aerosols of Mycobacterium tuberculosis: A New Method to Study Infectiousness
Fennelly, K. P., Martyny, J. W., Fulton, K. E., Orme, I. M., Cave, D. M., & Heifets, L. B. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1101oc · Cited by 327 · cited 1×
“tation, laryngeal TB, cough frequency, and sputum volume and consistency (86, 87, 92, 165, 206).”
BackgroundImmune Reconstitution Inflammatory Syndrome: A Reappraisal
French, M. A. (2009) · Clinical Infectious Diseases · doi:10.1086/595006 · Cited by 323 · cited 7×
“tuberculosis components, which serve as stimuli for the innate immune response and/or specific T cell responses, the partially reconstituted cellular immune response, and incomplete regulation of the reconstituted immune system (95, 182).”
BackgroundResultInfluentialExtrapulmonary Tuberculosis in Patients with Human Immunodeficiency Virus Infection
Shafer, R. W., Kim, D. S., Weiss, J. P., & Quale, J. M. (1991) · Medicine · doi:10.1097/00005792-199111000-00004 · Cited by 322 · cited 3×
“Symptoms of extrapulmonary TB (with or without concomitant pulmonary TB) in a cohort of 199 HIV-infected patients included fever (95%), respiratory symptoms (66%), lymphadenopathy (62%), gastrointestinal symptoms (37%) with diarrhea and abdominal pain, and neurological symptoms (29%), including confusion and headache…”
BackgroundGandhi, N. R., Shah, N. S., Andrews, J. R., Vella, V., Moll, A. P., Scott, M., Weissman, D., Marra, C., Lalloo, U. G., & Friedland, G. H. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-0989oc · Cited by 313 · cited 3×
“A subsequent retrospective study of all patients with MDR-TB or XDR-TB from Tugela Ferry from 2005 to 2007 found that of the 272 MDR-TB and 382 XDR-TB cases, 90% and 98% were coinfected with HIV with median CD4 counts of 41 cells/ l and 36 cells/ l and median HIV viral loads of 160,000 and 135,500 log10 copies/ml, res…”
BackgroundTuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa
Mukadi, Y. D., Maher, D., & Harries, A. (2001) · AIDS · doi:10.1097/00002030-200101260-00002 · Cited by 311 · cited 1×
“In other resource-limited settings, the reported casefatality rates prior to the availability antiretrovirals were extremely high: in the Central African Republic, the case-fatality rate was as high as 58% for HIV-infected patients, compared to 20% for HIV-uninfected patients at 24 months after the initiation of TB tr…”
ResultBruns, H., Meinken, C., Schauenberg, P., Härter, G., Kern, P., Modlin, R. L., Antoni, C., & Stenger, S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38482 · Cited by 307 · cited 1×
“to mycobacterial killing in in vitro assays (32, 189).”
BackgroundPerlman, D. C., El‐Sadr, W. M., Nelson, E. T., Matts, J. P., Telzak, E. E., Salomon, N., Chirgwin, K., & Hafner, R. (1997) · Clinical Infectious Diseases · doi:10.1086/514546 · Cited by 295 · cited 3×
“reactivation in HIV-uninfected patients (33, 102, 210, 214).”
BackgroundMethodImmune reconstitution inflammatory syndrome: more answers, more questions
Shelburne, S. A., Montes, M., & Hamill, R. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki444 · Cited by 286 · cited 1×
“Because there is no definitive laboratory test for TB-IRIS, TB-IRIS remains a clinical diagnosis after thorough investigation to exclude new opportunistic infections, TB treatment failure, drug toxicity, and other possible causes of clinical deterioration in a patient on TB treatment who has initiated antiretrovirals…”
BackgroundAn Algorithm for Tuberculosis Screening and Diagnosis in People with HIV
Cain, K. P., McCarthy, K. D., Heilig, C. M., Monkongdee, P., Tasaneeyapan, T., Kanara, N., Kimerling, M. E., Chheng, P., Thai, S., Sar, B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907488 · Cited by 279 · cited 3×
“predictors: cough of any duration, fever of any duration, or night sweats lasting 3 weeks or more during the previous 4 weeks (35).”
BackgroundInfluentialA Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis
Chen, C. Y., Huang, D., Wang, R. C., Shen, L., Zeng, G., Yao, S., Shen, Y., Halliday, L., Fortman, J., McAllister, M., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000392 · Cited by 278 · cited 19×
“The HIV Nef protein has also been reported to downregulate the surface expression of the costimulatory molecules CD80 and CD86 on antigen-presenting cells, which results in an impaired activation of naïve CD4 T cells (46).”
BackgroundInfluentialHIV-1 Nef impairs MHC class II antigen presentation and surface expression
Stumptner-Cuvelette, P., Morchoisne, S., Dugast, M., Le Gall, S., Raposo, G., Schwartz, O., & Benaroch, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221256498 · Cited by 274
Population Mobility, Globalization, and Antimicrobial Drug Resistance
MacPherson, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1511.090419 · Cited by 266
Blaak, H., van't Wout, A. B., Brouwer, M., Hooibrink, B., Hovenkamp, E., & Schuitemaker, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1269 · Cited by 262 · cited 1×
“After the initial phase of massive depletion of intestinal Th17 cells, the cells that are most markedly depleted from peripheral blood and secondary lymphoid tissues are effector memory cells, without known specificity for those with Th1, Th2, or Th17 phenotypes (21).”
BackgroundManosuthi, W., Chottanapand, S., Thongyen, S., Chaovavanich, A., & Sungkanuparph, S. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000230521.86964.86 · Cited by 258 · cited 1×
“A retrospective cohort analysis of 1,003 Thai patients coinfected with HIV and TB found that the initiation of ART within 6 months of TB diagnosis reduced mortality (169).”
BackgroundGreenberg, S. D., Frager, D., Suster, B., Walker, S., Stavropoulos, C., & Rothpearl, A. (1994) · Radiology · doi:10.1148/radiology.193.1.7916467 · Cited by 246
Desvignes, L., & Ernst, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.10.007 · Cited by 246 · cited 1×
“These findings clearly demonstrate a critical role for the cytokine IFN- in the immune control of TB in humans and are consistent with the results of experiments with mice that revealed essential roles for IFN- (56, 94) and IFN- receptors (72) in the control of M.”
ResultSelf-citationSubpopulations of long-lived and short-lived T cells in advanced HIV-1 infection
Hellerstein, M. K., Hoh, R., Hanley, M. B., Cesar, D., Lee, D. C., Neese, R. A., & McCune, J. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17533 · Cited by 243 · cited 1×
“In addition to increased CD4 T cell death induced by HIV, a decreased thymic output of naïve CD4 T cells in HIV-infected subjects results in an inability to replace CD4 T cells at the rate that they are destroyed (125, 126).”
BackgroundTuberculosis Morbidity—United States, 1994
(1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530100022010 · Cited by 241
A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis.
Colebunders, R., & Bastian, I. (2000) · PubMed · Cited by 239
Wood, R., Middelkoop, K., Myer, L., Grant, A. D., Whitelaw, A., Lawn, S. D., Kaplan, G., Huebner, R., McIntyre, J., & Bekker, L.-G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200606-759oc · Cited by 239 · cited 1×
“In contrast, a cross-sectional active case-finding survey of HIV and TB in a periurban slum community in South Africa found the estimated duration of undiagnosed and infectious TB to be slightly higher for HIV-infected persons ( 12 months) than for individuals without HIV ( 9 months) (270).”
BackgroundBartlett, J. G. (1998) · PubMed · Cited by 238
Jindani, A., Nunn, A., & Enarson, D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17141-9 · Cited by 238 · cited 1×
“Two studies which compared the use of RIF to the use of ethambutol (ETB) in the continuation phase after initial treatment with isoniazid (INH)-RIF-pyrazinamide (PZA)-ETB found that those on ETB-INH were 2 to 3 times more likely to experience treatment failure or TB relapse than those on RIF-INH for continuation thera…”
ResultApproaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings
Reid, M. J., & Shah, N. S. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70043-x · Cited by 237 · cited 3×
“Since a significant proportion of HIV-infected patients with active TB have less specific symptoms or have no symptoms, screening for cough alone will miss the majority of patients with culture-confirmed TB (217).”
BackgroundLawn, S. D., Bekker, L.-G., Middelkoop, K., Myer, L., & Wood, R. (2006) · Clinical Infectious Diseases · doi:10.1086/501018 · Cited by 233 · cited 2×
“For each 1% increase in HIV prevalence, TB notification rates increased by 55 cases per 100,000 persons in 1998 to 1999 and increased by 81 cases per 100,000 persons in 2004 (154).”
BackgroundGeldmacher, C., Ngwenyama, N., Schuetz, A., Petrovas, C., Reither, K., Heeregrave, E. J., Casazza, J. P., Ambrozak, D. R., Louder, M., Ampofo, W., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100090 · Cited by 232
Host Control of HIV-1 Parasitism in T Cells by the Nuclear Factor of Activated T Cells
Kinoshita, S., Chen, B. K., Kaneshima, H., & Nolan, G. P. (1998) · Cell · doi:10.1016/s0092-8674(00)81630-x · Cited by 227 · cited 1×
“First, T cell antigen receptor (TCR) signaling activates the transcription factor NFATc (nuclear factor of activated T cells-c), which activates the reverse transcription of HIV (147).”
BackgroundSadek, M. I., Sada, E., Toossi, Z., Schwander, S. K., & Rich, E. A. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.3.2815 · Cited by 227 · cited 1×
“tuberculosis is a potent inducer of these chemokines in primary macrophages (221, 224), indicating that at least in certain local environments, there may be inhibitory effects of M.”
BackgroundMcIlleron, H., Meintjes, G., Burman, W. J., & Maartens, G. (2007) · The Journal of Infectious Diseases · doi:10.1086/518655 · Cited by 226 · cited 1×
“Detailed reviews of the interactions between rifampin and antiretrovirals have been reported elsewhere (40, 178), and information on the management of drug interactions for the treatment of HIV and TB coinfection can be found at the CDC website (http://www.”
BackgroundWeiner, M., Benator, D., Burman, W., Peloquin, C. A., Khan, A., Vernon, A., Jones, B., Silva-Trigo, C., Zhao, Z., Hodge, T., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/429321 · Cited by 226 · cited 1×
“Subtherapeutic levels of rifabutin have been associated with the development of acquired rifamycin resistance (257).”
BackgroundMase, S., Ramsay, A., Ng, V., Henry, M., Hopewell, P. C., Cunningham, J., Urbanczik, R., Perkins, M. D., Aziz, M. A., & Pai, M. (2007) · PubMed · Cited by 224
Menzies, D., Benedetti, A., Paydar, A., Martin, I., Royce, S., Pai, M., Vernon, A., Lienhardt, C., & Burman, W. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000146 · Cited by 222 · cited 1×
“Several meta-analyses have shown that treatment with a longer duration (6 months or longer) of a rifamycin drug (rifampin or rifabutin [RfB]) resulted in lower rates of failure and recurrence and improved survival during treatment, compared to only 2 months of treatment with a rifamycin drug (146, 150, 186).”
BackgroundDivangahi, M., Mostowy, S., Coulombe, F., Kozak, R., Guillot, L., Veyrier, F., Kobayashi, K. S., Flavell, R. A., Gros, P., & Behr, M. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7157 · Cited by 213 · cited 2×
“tuberculosis activates proinflammatory responses of macrophages by signaling through Toll-like receptor 2 (TLR2) and TLR4 (179) and through nucleotide-binding oligomerization domain 2 (NOD2) (77, 93) and by inducing the secretion of the cytokine TNF.”
BackgroundAckah, A. N., Digbeu, H., Daillo, K., Greenberg, A. E., Coulibaly, D., Coulibaly, I.-M., Vetter, K. M., & de Cock, K. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90519-7 · Cited by 208 · cited 2×
“A study from Côte d’Ivoire showed that mortality rates for coinfected patients prior to the availability of antiretroviral treatment were related to the degree of immune deficiency (7).”
BackgroundC-C chemokines, pivotal in protection against HIV type 1 infection
Zagury, D., Lachgar, A., Chams, V., Fall, L. S., Bernard, J., Zagury, J.-F., Bizzini, B., Gringeri, A., Santagostino, E., Rappaport, J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3857 · Cited by 205 · cited 5×
“A prospective study from New York City found significantly higher rates of TB, AIDS, and death for substance users on welfare than for the general population of New York City (risk ratios of 15, 10, and 5, respectively) (100).”
BackgroundInfluentialThe Antiretroviral Therapy Cohort Collaboration (2005) · Clinical Infectious Diseases · doi:10.1086/498315 · Cited by 203 · cited 1×
“The use of ART and immunological recovery, a rise in CD4 counts, significantly decreased the incidence of TB, with the greatest effect on patients with restored CD4 cell counts above 500 cells/ l (14, 113, 151, 156, 223).”
MethodBoulle, A. (2008) · JAMA · doi:10.1001/jama.300.5.530 · Cited by 201 · cited 3×
“However, a large prospective cohort study in South Africa and a randomized clinical trial in Thailand failed to show any adverse effect on virologic suppression when a standard dose of efavirenz (600 mg daily) was used with rifampin (29, 170, 171).”
BackgroundMethodBasu, S., Andrews, J. R., Poolman, E. M., Gandhi, N. R., Shah, N. S., Moll, A., Moodley, P., Galvani, A. P., & Friedland, G. H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61636-5 · Cited by 201 · cited 1×
“Together, these studies highlight the need for effective infection control and ventilation as components of comprehensive strategies to prevent the spread of TB and drug-resistant TB to HIV-infected patients in waiting rooms, clinics, and hospital wards (18, 268).”
BackgroundFrieden, T. R. (1996) · JAMA · doi:10.1001/jama.1996.03540150031027 · Cited by 199 · cited 1×
“That hospitals and prisons with poor or inconsistent infection control practices can serve as locations for the spread of TB to persons infected with HIV was documented in the early 1990s in New York and Florida (38, 41, 43, 97, 98).”
BackgroundTuberculosis Diagnosis — Time for a Game Change
Small, P. M., & Pai, M. (2010) · New England Journal of Medicine · doi:10.1056/nejme1008496 · Cited by 196 · cited 1×
“Simple, rapid diagnostics that can replace direct sputum smear microscopy are urgently needed for resource-constrained health care systems (232).”
BackgroundOutcome of HIV‐Associated Tuberculosis in the Era of Highly Active Antiretroviral Therapy
Dheda, K., Lampe, F. C., Johnson, M. A., & Lipman, M. C. (2004) · The Journal of Infectious Diseases · doi:10.1086/424676 · Cited by 195 · cited 1×
“Incidence rates of paradoxical TB-IRIS range from 8% to 43%, and the majority of TB-IRIS occurs within the first 4 to 8 weeks after the initiation of ART (54, 73, 152, 182).”
BackgroundEpidemiology of HIV-associated tuberculosis
Lawn, S. D., & Churchyard, G. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832c7d61 · Cited by 192 · cited 1×
“Deaths due to TB accounted for one-quarter of the estimated 2 million HIV-related deaths worldwide in 2008, and TB is the leading cause of death for people living with HIV in low- and middle-income countries (155, 250, 262, 263).”
BackgroundCavitary Disease and Quantitative Sputum Bacillary Load in Cases of Pulmonary Tuberculosis
Palaci, M., Dietze, R., Hadad, D. J., Ribeiro, F. K. C., Peres, R. L., Vinhas, S. A., Maciel, E. L. N., do Valle Dettoni, V., Horter, L., Boom, W. H., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01780-07 · Cited by 192 · cited 1×
“tation, laryngeal TB, cough frequency, and sputum volume and consistency (86, 87, 92, 165, 206).”
BackgroundThe association of housing density, isolation and tuberculosis in Canadian First Nations communities
Clark, M., Riben, P., & Nowgesic, E. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.5.940 · Cited by 185
Geldmacher, C., Schuetz, A., Ngwenyama, N., Casazza, J. P., Sanga, E., Saathoff, E., Boehme, C., Geis, S., Maboko, L., Singh, M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/593017 · Cited by 185 · cited 1×
“In contrast, another study analyzed the frequency of IFN- -secreting cells after stimulation with recombinant ESAT-6 or CFP-10 proteins and reported that a lower proportion of HIV-infected individuals had specific responses above a defined cutoff of responding cells (109).”
ResultZhang, Y., Nakata, K., Weiden, M., & Rom, W. N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117924 · Cited by 182 · cited 1×
“tuberculosis-infected regions of the lungs than in the uninvolved regions of the same patient (274).”
BackgroundHuman Immunodeficiency Virus and the Prevalence of Undiagnosed Tuberculosis in African Gold Miners
Corbett, E. L., Charalambous, S., Moloi, V. M., Fielding, K., Grant, A. D., Dye, C., De Cock, K. M., Hayes, R. J., Williams, B. G., & Churchyard, G. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-590oc · Cited by 182 · cited 2×
“Two studies, one of South African gold miners and one of workers in Harare, Zimbabwe, demonstrated a significantly shorter mean duration of infectiousness of TB in HIV-infected patients than in patients without HIV (58, 59).”
BackgroundResultThe Infectiousness of Tuberculosis Patients Coinfected with HIV
Escombe, A. R., Moore, D. A. J., Gilman, R. H., Pan, W., Navincopa, M., Ticona, E., Martínez, C., Caviedes, L., Sheen, P., Gonzalez, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050188 · Cited by 182 · cited 4×
“A study from Lima, Peru, measured air changes per hour and estimated the TB transmission risk for a variety of hospital rooms, including “old-fashioned” rooms with large open windows and high ceilings (built pre-1950), “modern” hospital rooms (built in 1970 to 1990), and more recently constructed mechanical ventilatio…”
BackgroundInfluentialAntimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis
Cho, S., Mehra, V., Thoma-Uszynski, S., Stenger, S., Serbina, N., Mazzaccaro, R. J., Flynn, J. L., Barnes, P. F., Southwood, S., Celis, E., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210391497 · Cited by 181 · cited 1×
“in vitro (49, 137, 238) and contribute to the killing of mycobac-”
BackgroundDeaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1
Harries, A. D., Hargreaves, N. J., Kemp, J., Jindani, A., Enarson, D. A., Maher, D., & Salaniponi, F. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04639-0 · Cited by 181 · cited 1×
“The higher case-fatality rate of TB in HIV-infected individuals is likely due to a combination of factors associated with HIV coinfection: (i) the rapid progression of disease due to the failure of immune responses to restrict the growth of Mycobacterium tuberculosis, (ii) delayed diagnosis and treatment of TB infecti…”
BackgroundGeng, E., Kreiswirth, B., Burzynski, J., & Schluger, N. W. (2005) · JAMA · doi:10.1001/jama.293.22.2740 · Cited by 181 · cited 1×
“primary TB infection in HIV-infected patients (110).”
Whalen, C. C., Nsubuga, P., Okwera, A., Johnson, J. L., Hom, D. L., Michael, N. L., Mugerwa, R. D., & Ellner, J. J. (2000) · AIDS · doi:10.1097/00002030-200006160-00020 · Cited by 176 · cited 1×
“Similarly, a prospective cohort study in Uganda that evaluated the impact of TB on the survival of HIV-infected patients found a 3-fold-higher risk of death for patients whose CD4 counts were greater than 200 cells/ l but did not find a significant effect of TB on mortality for patients with advanced immunodeficiency…”
ResultJoosten, S. A., van Meijgaarden, K. E., van Weeren, P. C., Kazi, F., Geluk, A., Savage, N. D. L., Drijfhout, J. W., Flower, D. R., Hanekom, W. A., Klein, M. R., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000782 · Cited by 176 · cited 1×
“in vitro (49, 137, 238) and contribute to the killing of mycobac-”
BackgroundTuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
Shafer, R. W., & Edlin, B. R. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.4.683 · Cited by 174 · cited 2×
“In populations of immunocompetent people, 3 to 5% will develop active TB in the first 2 years after TB infection (99, 188, 219, 228).”
BackgroundDheda, K., Smit, R. V. Z., Badri, M., & Pai, M. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32832a0adc · Cited by 174 · cited 2×
“linked immunospot (ELISPOT) technique (24, 74).”
BackgroundDiedrich, C. R., Mattila, J. T., Klein, E., Janssen, C., Phuah, J., Sturgeon, T. J., Montelaro, R. C., Lin, P. L., & Flynn, J. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009611 · Cited by 173 · cited 1×
“Likewise, the depletion of CD4 (76) or CD8 (48) cells from M.”
BackgroundVirological and Immunological Impact of Tuberculosis on Human Immunodeficiency Virus Type 1 Disease
Toossi, Z. (2003) · The Journal of Infectious Diseases · doi:10.1086/378676 · Cited by 172 · cited 1×
“It is thought that the increased proinflammatory response with active TB plays a role in increasing HIV transcription, as higher levels of tumor necrosis factor alpha (TNF- ) are associated with higher viral loads in patients coinfected with HIV and TB (245).”
BackgroundMonkongdee, P., McCarthy, K. D., Cain, K. P., Tasaneeyapan, T., Dung, N. H., Lan, N. T. N., Yen, N. T. B., Teeratakulpisarn, N., Udomsantisuk, N., Heilig, C. M., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0692oc · Cited by 172 · cited 1×
“An evaluation of sputum smears and cultures from HIV-infected persons with culture-confirmed TB in Thailand and Vietnam found the sensitivity of three sputum smears to be only 38% (195, 211).”
BackgroundImpact of tuberculosis (TB) on HIV-1 activity in dually infected patients
Toossi, Z., Mayanja-Kizza, H., Hirsch, C. S., Edmonds, K. L., Spahlinger, T., Hom, D. L., Aung, H., Mugyenyi, P., Ellner, J. J., & Whalen, C. W. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2001.01401.x · Cited by 167 · cited 1×
“The development of TB is associated with increased HIV replication, as measured by the viral load at the site of TB infection in the lungs as well as by the plasma viral load (246, 247).”
BackgroundSantoro-Lopes, G., Felix de Pinho, A. M., Harrison, L. H., & Schechter, M. (2002) · Clinical Infectious Diseases · doi:10.1086/338641 · Cited by 167 · cited 1×
“The use of ART and immunological recovery, a rise in CD4 counts, significantly decreased the incidence of TB, with the greatest effect on patients with restored CD4 cell counts above 500 cells/ l (14, 113, 151, 156, 223).”
MethodAichelburg, M. C., Rieger, A., Breitenecker, F., Pfistershammer, K., Tittes, J., Eltz, S., Aichelburg, A. C., Stingl, G., Makristathis, A., & Kohrgruber, N. (2009) · Clinical Infectious Diseases · doi:10.1086/597351 · Cited by 165
β-Chemokines Are Induced byMycobacterium tuberculosisand Inhibit Its Growth
Saukkonen, J. J., Bazydlo, B., Thomas, M., Strieter, R. M., Keane, J., & Kornfeld, H. (2002) · Infection and Immunity · doi:10.1128/iai.70.4.1684-1693.2002 · Cited by 163 · cited 1×
“tuberculosis is a potent inducer of these chemokines in primary macrophages (221, 224), indicating that at least in certain local environments, there may be inhibitory effects of M.”
BackgroundKorenromp, E. L., Scano, F., Williams, B. G., Dye, C., & Nunn, P. P. (2003) · Clinical Infectious Diseases · doi:10.1086/375220 · Cited by 163 · cited 1×
“Several meta-analyses have shown that treatment with a longer duration (6 months or longer) of a rifamycin drug (rifampin or rifabutin [RfB]) resulted in lower rates of failure and recurrence and improved survival during treatment, compared to only 2 months of treatment with a rifamycin drug (146, 150, 186).”
BackgroundCough frequency and infectivity in patients with pulmonary tuberculosis.
Loudon, R. G., & Spohn, S. K. (1969) · PubMed · doi:10.1164/arrd.1969.99.1.109 · Cited by 162 · cited 1×
“tation, laryngeal TB, cough frequency, and sputum volume and consistency (86, 87, 92, 165, 206).”
BackgroundTreatment of Active Tuberculosis in HIV‐Coinfected Patients: A Systematic Review and Meta‐Analysis
Khan, F. A., Minion, J., Pai, M., Royce, S., Burman, W., Harries, A. D., & Menzies, D. (2010) · Clinical Infectious Diseases · doi:10.1086/651686 · Cited by 161 · cited 3×
“Several meta-analyses have shown that treatment with a longer duration (6 months or longer) of a rifamycin drug (rifampin or rifabutin [RfB]) resulted in lower rates of failure and recurrence and improved survival during treatment, compared to only 2 months of treatment with a rifamycin drug (146, 150, 186).”
BackgroundWenning, L. A., Hanley, W. D., Brainard, D. M., Petry, A. S., Ghosh, K., Jin, B., Mangin, E., Marbury, T. C., Berg, J. K., Chodakewitz, J. A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01468-08 · Cited by 161 · cited 2×
“For integrase inhibitors and entry inhibitors, studies now indicate that rifampin significantly accelerates the metabolism of raltegravir and maraviroc and results in subtherapeutic levels of the antiretroviral drugs when administered at standard doses (85, 258).”
BackgroundUrbanization — An Emerging Humanitarian Disaster
Patel, R. B., & Burke, T. F. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0810878 · Cited by 158 · cited 1×
“Key features of slum life, such as crowded housing, working conditions with poor ventilation, poor nutrition, and lack of access to quality health care, continue to drive TB transmission (20, 209, 251).”
BackgroundIn a novel form of IFN-γ receptor 1 deficiency, cell surface receptors fail to bind IFN-γ
Jouanguy, E., Dupuis, S., Pallier, A., Döffinger, R., Fondanèche, M.-C., Fieschi, C., Lamhamedi-Cherradi, S., Altare, F., Emile, J.-F., Lutz, P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9166 · Cited by 157 · cited 1×
“bovis BCG, have revealed mutations in the gene encoding a subunit of the IFN- receptor (139), and further studies have revealed IFNreceptor mutations in certain HIV-negative patients with severe and/or recurrent TB (139, 140).”
BackgroundHIV Infection–Related Tuberculosis: Clinical Manifestations and Treatment
Sterling, T. R., Pham, P. A., & Chaisson, R. E. (2010) · Clinical Infectious Diseases · doi:10.1086/651495 · Cited by 153 · cited 3×
“The clinical presentation of TB in HIV-infected persons has been reviewed extensively elsewhere (15, 33, 142, 239).”
BackgroundMethodMeintjes, G., Wilkinson, K. A., Rangaka, M. X., Skolimowska, K. H., van Veen, K., Abrahams, M., Seldon, R., Pepper, D. J., Rebe, K. B., Mouton, P., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200806-858oc · Cited by 153 · cited 1×
“TB-IRIS inflammation is characteristic of a Th1 immune response, although a Th17 response has not been excluded (82, 95, 184).”
BackgroundAssociation between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.
Badri, M., Ehrlich, R. I., Wood, R., Pulerwitz, T., & Maartens, G. (2001) · PubMed · Cited by 151
Demo, A. G., Moss, R. B., Margolick, J. B., Cleghorn, F. R., Sill, A. M., Blattner, W. A., Cocchi, F., Carlo, D. J., DeVico, A. L., & Gallo, R. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11986 · Cited by 148 · cited 5×
“A prospective study from New York City found significantly higher rates of TB, AIDS, and death for substance users on welfare than for the general population of New York City (risk ratios of 15, 10, and 5, respectively) (100).”
BackgroundInfluentialAndrews, J. R., Gandhi, N. R., Moodley, P., Shah, N. S., Bohlken, L., Moll, A. P., Pillay, M., Friedland, G. H., & Sturm, A. W. (2008) · The Journal of Infectious Diseases · doi:10.1086/592991 · Cited by 148 · cited 26×
“The use of NVP with rifampin was associated with higher rates of virologic failure starting at 6 months after the initiation of treatment in a South African prospective cohort study (29).”
BackgroundInfluentialIannello, A., Boulassel, M., Samarani, S., Débbeche, O., Tremblay, C. L., Toma, E., Routy, J., & Ahmad, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901967 · Cited by 147 · cited 1×
“T cell counts (130, 131), indicating that CD4 T cells are an”
BackgroundHIV-1 Infection Impairs the Bronchoalveolar T-Cell Response to Mycobacteria
Kalsdorf, B., Scriba, T. J., Wood, K. J., Day, C. L., Dheda, K. U. J., Dawson, R., Hanekom, W. A., Lange, C. G., & Wilkinson, R. J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1011oc · Cited by 146 · cited 1×
“tuberculosis-specific CD4 T cells in the lungs (141).”
BackgroundFrieden, T. R., Sherman, L. F., Maw, K. L., Fujiwara, P. I., Crawford, J. T., Nivin, B., Sharp, V., Hewlett, D., Brudney, K. F., Alland, D., et al. (1996) · PubMed · Cited by 141
Escombe, A. R., Oeser, C., Gilman, R. H., Navincopa, M., Ticona, E., Martinez, C., Caviedes, L., Sheen, P., Gonzalez, A., Noakes, C., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/515397 · Cited by 137 · cited 4×
“A study from Lima, Peru, measured air changes per hour and estimated the TB transmission risk for a variety of hospital rooms, including “old-fashioned” rooms with large open windows and high ceilings (built pre-1950), “modern” hospital rooms (built in 1970 to 1990), and more recently constructed mechanical ventilatio…”
BackgroundInfluentialMwandumba, H. C., Russell, D. G., Nyirenda, M. H., Anderson, J., White, S. A., Molyneux, M. E., & Squire, S. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4592 · Cited by 136 · cited 1×
“tuberculosis, most (200) but not all (252) of the bacteria reside in membrane-bound phagosomes, which, through a vesicular pathway, deliver peptide antigens bound to HLA class II molecules to the cell surface.”
BackgroundCorbett, E. L., Bandason, T., Cheung, Y. B., Munyati, S. S., Godfrey‐Faussett, P., Hayes, R., Churchyard, G., Butterworth, A. E., & Mason, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0040022 · Cited by 135 · cited 2×
“5 months for HIV-infected patients, compared to 12 months for those without HIV (58).”
ResultKinter, A. L., Ostrowski, M., Goletti, D., Oliva, A., Weissman, D., Gantt, K. R., Hardy, E. C., Jackson, R. W., Ehler, L. A., & Fauci, A. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14076 · Cited by 134 · cited 1×
“The chemokine ligands that use CCR5 (MIP-1 /CCL3, MIP-1 /CCL4, and RANTES/CCL5) effectively compete with HIV for CCR5 and inhibit the infection of CCR5-expressing cells (148).”
BackgroundMukadi, Y. D., Wiktor, S. Z., Coulibaly, I., Coulibaly, D., Mbengue, A., Folquet, A., Ackah, A., Sassan‐Morokro, M., Bonnard, D., Maurice, C., et al. (1997) · AIDS · doi:10.1097/00002030-199709000-00011 · Cited by 129 · cited 1×
“Data were pooled from 12 studies (6, 19, 34, 66, 71, 105, 143, 144, 159, 199, 208, 210) that examined the frequency of lung cavitation associated with CD4 counts in patients coinfected with HIV and pulmonary TB.”
MethodImpact of tuberculosis on HIV-1 replication, diversity, and disease progression.
Collins, K. R., Quiñones‐Mateu, M. E., Toossi, Z., & Arts, E. J. (2002) · PubMed · Cited by 128
Minion, J., Leung, E., Menzies, D., & Pai, M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70165-1 · Cited by 127 · cited 1×
“Microscopic observation drug susceptibility (MODS) assays have been developed for the diagnosis of TB and the detection of drug-resistant TB (191, 192).”
MethodPost, F. A., Wood, R., & Pillay, G. P. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90527-8 · Cited by 123 · cited 2×
“reactivation in HIV-uninfected patients (33, 102, 210, 214).”
BackgroundPulmonary tuberculosis: comparison of CT findings in HIV-seropositive and HIV-seronegative patients.
Leung, A. N. C., Brauner, M., Gamsu, G., Mlika-Cabanne, N., Romdhane, H. B., Carette, M. F., & Greniér, P. (1996) · Radiology · doi:10.1148/radiology.198.3.8628855 · Cited by 123 · cited 1×
“Data were pooled from 12 studies (6, 19, 34, 66, 71, 105, 143, 144, 159, 199, 208, 210) that examined the frequency of lung cavitation associated with CD4 counts in patients coinfected with HIV and pulmonary TB.”
MethodCavitary Pulmonary Lesions in Patients Infected with Human Immunodeficiency Virus
Gallant, J. E., & Ko, A. H. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.4.671 · Cited by 123 · cited 2×
“reactivation in HIV-uninfected patients (33, 102, 210, 214).”
BackgroundLi, J., Munsiff, S. S., Driver, C. R., & Sackoff, J. E. (2005) · Clinical Infectious Diseases · doi:10.1086/430377 · Cited by 122 · cited 1×
“Daily dosing of rifampin in the initial phase of treatment is critical to prevent the development of relapse or treatment failure due to acquired rifampin resistance in HIVinfected patients with TB (146, 160).”
BackgroundElliott, J., Vohith, K., Saramony, S., Chin, S., Dara, C., Sarim, C., Huffam, S., Oelrichs, R. B., Sophea, P., Saphonn, V., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/644784 · Cited by 119 · cited 1×
“TB-IRIS inflammation is characteristic of a Th1 immune response, although a Th17 response has not been excluded (82, 95, 184).”
BackgroundA role for dendritic cells in the dissemination of mycobacterial infection
Humphreys, I. R., Stewart, G. R., Turner, D. J., Patel, J., Karamanou, D. M., Snelgrove, R. J., & Young, D. B. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.12.023 · Cited by 118 · cited 1×
“tuberculosis resides in macrophages has been known at least since the studies of Sabin and colleagues in the 1920s (65, 220), although the spectrum of cells in which the bacteria reside in vivo has been recently found to include myeloid dendritic cells (129, 244, 269).”
ResultManosuthi, W., D, S. S. M., Tantanathip, P., Lueangniyomkul, A., Mankatitham, W., Prasithsirskul, W., Burapatarawong, S., Thongyen, S., Likanonsakul, S., Thawornwa, U., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/599114 · Cited by 117 · cited 2×
“However, a large prospective cohort study in South Africa and a randomized clinical trial in Thailand failed to show any adverse effect on virologic suppression when a standard dose of efavirenz (600 mg daily) was used with rifampin (29, 170, 171).”
MethodKabeer, B. S. A., Raman, B., Thomas, A., Venkatesan, P., & Raja, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009051 · Cited by 115
Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources.
Colebunders, R., John, L., Huyst, V., Kambugu, A., Scano, F., & Lynen, L. (2006) · PubMed · Cited by 115
Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed
Miller, E. A., & Ernst, J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39143 · Cited by 113 · cited 1×
“to mycobacterial killing in in vitro assays (32, 189).”
BackgroundSelf-citationVelasco, M., Castilla, V., Sanz, J., Gaspar, G., Condés, E., Barros, C., Cervero, M., Torres, R., & Guijarro, C. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31819367e7 · Cited by 112 · cited 2×
“7% mortality with starting ART after 8 weeks), even though there was no difference in median initial CD4 counts between the two groups (253).”
BackgroundTuberculosis, AIDS, and Death among Substance Abusers on Welfare in New York City
Friedman, L. N., Williams, M. T., Singh, T. P., & Frieden, T. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341304 · Cited by 111 · cited 1×
“A prospective study from New York City found significantly higher rates of TB, AIDS, and death for substance users on welfare than for the general population of New York City (risk ratios of 15, 10, and 5, respectively) (100).”
BackgroundMeintjes, G., Rangaka, M. X., Maartens, G., Rebe, K. B., Morroni, C., Pepper, D. J., Wilkinson, K. A., & Wilkinson, R. J. (2009) · Clinical Infectious Diseases · doi:10.1086/596764 · Cited by 110 · cited 1×
“In one cohort of 100 patients with suspected TB-IRIS, 7 had an alternative opportunistic disease, and 13 had rifampin-resistant TB (183).”
BackgroundTuberculosis in New York city: recent lessons and a look ahead
Paolo, W. F., & Nosanchuk, J. D. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01004-7 · Cited by 109 · cited 1×
“The association between poverty, urbanization, housing density, and TB incidence is well documented (27, 50, 164, 207).”
BackgroundTuberculosis: A Comprehensive Clinical Reference
Schaaf, H. S., & Zumla, A. I. (2009) · Cited by 108
Okwera, A., Byekwaso, F., Mugerwa, M., Okwera, A., Byekwaso, F., Ellner, J. J., Vjecha, M. J., Johnson, J. L., Whalen, C., & Huebner, R. E. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90693-9 · Cited by 107 · cited 1×
“In a randomized trial comparing rifampin- to thiacetazone-based initial and continuation phase regimens for pulmonary TB in HIV-infected patients, treatment with the rifampin-based regimen improved survival (203).”
BackgroundProviding HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
Harries, A. D., Zachariah, R., & Lawn, S. D. (2009) · PubMed · Cited by 106
Espinal, M., Pérez-Then, E. N., Baéz, J., Hénriquez, L., Fernández, K., Lopez, M. J., Olivo, P., & Reingold, A. L. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04402-5 · Cited by 105 · cited 1×
“A prospective cohort study in the Dominican Republic of over 800 household contacts of 58 HIV-infected and 116 matched HIVuninfected index cases with newly diagnosed smear-positive or culture-positive pulmonary TB found that HIV-infected index cases were half as likely as HIV-uninfected index cases to transmit TB to t…”
BackgroundAabye, M. G., Ravn, P., PrayGod, G., Jeremiah, K., Mugomela, A., Jepsen, M., Faurholt‐Jepsen, D., Range, N. S., Friis, H., Changalucha, J. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004220 · Cited by 105
Direct Measurement of CD4+ and CD8+ T-Cell Responses to CMV in HIV-1-Infected Subjects
Komanduri, K. V., Donahoe, S. M., Moretto, W. J., Schmidt, D. K., Gillespie, G. M. A., Ogg, G. S., Roederer, M., Nixon, D. F., & McCune, J. M. (2001) · Virology · doi:10.1006/viro.2000.0697 · Cited by 104 · cited 1×
“the number of CMV-responsive CD4 T cells (149), consistent”
BackgroundMeintjes, G., Rabie, H., Wilkinson, R. J., & Cotton, M. F. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.08.013 · Cited by 103 · cited 6×
“Incidence rates of paradoxical TB-IRIS range from 8% to 43%, and the majority of TB-IRIS occurs within the first 4 to 8 weeks after the initiation of ART (54, 73, 152, 182).”
BackgroundResultInfluentialCD4 T Lymphocyte Count and the Radiographic Presentation of Pulmonary Tuberculosis
Keiper, M. D., Beumont, M. G., Elshami, A. A., Langlotz, C. P., & Miller, W. T. (1995) · CHEST Journal · doi:10.1378/chest.107.1.74 · Cited by 102 · cited 1×
“Data were pooled from 12 studies (6, 19, 34, 66, 71, 105, 143, 144, 159, 199, 208, 210) that examined the frequency of lung cavitation associated with CD4 counts in patients coinfected with HIV and pulmonary TB.”
MethodManagement of individuals requiring antiretroviral therapy and TB treatment
Cohen, K., & Meintjes, G. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283339309 · Cited by 101 · cited 2×
“Some experts have suggested avoiding the lead-in phase of NVP (commonly used to decrease side effects) and starting NVP at the twice-daily full dose with concomitant rifampin use in order to minimize the pharmacokinetic impact of rifampin on NVP and to improve virologic outcomes (52, 123).”
BackgroundBoulanger, C., Hollender, E. S., Farrell, K., Stambaugh, J. J., Maasen, D., Ashkin, D., Symes, S. N., Espinoza, L. A., Rivero, R. O., Graham, J. J., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/606056 · Cited by 100 · cited 4×
“Rifabutin drug concentration monitoring may be warranted during treatment when it is feasible (28).”
BackgroundInfluentialCorbett, E. L., Zezai, A., Cheung, Y. B., Bandason, T., Dauya, E., Munyati, S. S., Butterworth, A. E., Rusikaniko, S., Churchyard, G., Mungofa, S., et al. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.055467 · Cited by 99 · cited 1×
“2% positive predictive value for TB (both culture-positive and culture-negative TB) (63).”
BackgroundLeidl, L., Mayanja‐Kizza, H., Sotgiu, G., Baseke, J., Ernst, M., Hirsch, C. S., Goletti, D., Toossi, Z., & Lange, C. G. (2009) · European Respiratory Journal · doi:10.1183/09031936.00045509 · Cited by 99
The Nef Protein of HIV-1 Induces Loss of Cell Surface Costimulatory Molecules CD80 and CD86 in APCs
Chaudhry, A., Das, S. R., Hussain, A., Mayor, S., George, A., Bal, V., Jameel, S., & Rath, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4566 · Cited by 98 · cited 1×
“The HIV Nef protein has also been reported to downregulate the surface expression of the costimulatory molecules CD80 and CD86 on antigen-presenting cells, which results in an impaired activation of naïve CD4 T cells (46).”
BackgroundTuberculous meningitis in HIV-infected individuals
Vinnard, C., & Macgregor, R. R. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0019-7 · Cited by 96
Contribution of reinfection to recurrent tuberculosis in South African gold miners.
Charalambous, S., Grant, A. D., Moloi, V., Warren, R. M., Day, J. H., van Helden, P. D., Hayes, R., Fielding, K., Cock, K. M. D., Chaisson, R. E., et al. (2008) · PubMed · Cited by 94
Physiologic activation of T cells via the T cell receptor induces NF-kappa B
Jamieson, C. A. M., McCaffrey, P. G., Rao, A., & Sen, R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.2.416 · Cited by 93 · cited 1×
“Second, TCR stimulation, together with CD28 engagement, activates NF- B (132), which increases the transcription of HIV.”
BackgroundBatungwanayo, J., Taelman, H., Dhôte, R., Bogaerts, J., Allen, S., & de Perre, P. V. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.1.53 · Cited by 92 · cited 1×
“Data were pooled from 12 studies (6, 19, 34, 66, 71, 105, 143, 144, 159, 199, 208, 210) that examined the frequency of lung cavitation associated with CD4 counts in patients coinfected with HIV and pulmonary TB.”
MethodAn ecological analysis of incidence of tuberculosis andper capitagross domestic product: Fig. 1—
Janssens, J.-P., & Rieder, H. L. (2008) · European Respiratory Journal · doi:10.1183/09031936.00078708 · Cited by 92 · cited 1×
“The level of poverty, as measured by the gross domestic product per capita, is directly related to the incidence of TB (133).”
BackgroundESCRT factors restrict mycobacterial growth
Philips, J. A., Porto, M. C., Wang, H., Rubin, E. J., & Perrimon, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707206105 · Cited by 89 · cited 1×
“protein tsg101, as being essential for restricting the growth of avirulent or attenuated mycobacteria (213), suggesting that virulent M.”
BackgroundMiddelkoop, K., Bekker, L., Myer, L., Dawson, R., & Wood, R. (2008) · Clinical Infectious Diseases · doi:10.1086/589750 · Cited by 89 · cited 1×
“A third study from South Africa found that the ARTI was unchanged from 1999 to 2005, while the HIV prevalence increased from 14% to 23% during that period (187).”
BackgroundCorbett, E. L., Bandason, T., Cheung, Y.-B., Makamure, B., Dauya, E., Munyati, S. S., Churchyard, G., Williams, B. G., Butterworth, A. E., Mungofa, S., et al. (2009) · PubMed · Cited by 88
Annual risk of infection withMycobacterium tuberculosis
Rieder, H. L. (2005) · European Respiratory Journal · doi:10.1183/09031936.04.00103804 · Cited by 85
Modi, W., Lautenberger, J., An, P., Scott, K., Goedert, J., Kirk, G., Buchbinder, S., Phair, J., Donfield, S., O'Brien, S., et al. (2006) · American Journal of Human Genetics · doi:10.1086/505331 · Cited by 84 · cited 5×
“A prospective study from New York City found significantly higher rates of TB, AIDS, and death for substance users on welfare than for the general population of New York City (risk ratios of 15, 10, and 5, respectively) (100).”
BackgroundInfluentialEmmelkamp, J. M., & Rockstroh, J. K. (2007) · PubMed · Cited by 82
The Impact of Human Immunodeficiency Virus Type 1 on Infectiousness of Tuberculosis: A Meta‐Analysis
Cruciani, M., Malena, M., Bosco, O., Gatti, G., & Serpelloni, G. (2001) · Clinical Infectious Diseases · doi:10.1086/324352 · Cited by 82 · cited 1×
“A meta-analysis of eight studies comparing the prevalences of TST positivity among household contacts of TB index cases found a lower rate of TST positivity among contacts of HIV-infected than among contacts of HIV-uninfected index TB cases (64).”
Transmission of tuberculosis in San Francisco and its association with immigration and ethnicity.
Borgdorff, M. W., Behr, M. A., Nagelkerke, N. J. D., Hopewell, P. C., & Small, P. M. (2000) · PubMed · Cited by 81
Toossi, Z., Sierra-Madero, J. G., Blinkhorn, R., Mettler, M. A., & Rich, E. A. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.5.1511 · Cited by 81 · cited 2×
“Early after the recognition that TB and HIV were converging to amplify the problems that each of the epidemics posed alone (231), peripheral blood monocytes from patients with active TB were found to be more susceptible to productive infection by HIV in vitro (247).”
BackgroundHigh Rates of Recurrence in HIV‐Infected and HIV‐Uninfected Patients with Tuberculosis
Glynn, J. R., Murray, J., Bester, A. J., Nelson, G., Shearer, S., & Sonnenberg, P. (2010) · The Journal of Infectious Diseases · doi:10.1086/650529 · Cited by 79 · cited 1×
“HIV-infected patients appear to be at a higher risk for reinfection with TB, likely because of an impaired capacity to mount long-lasting protective immune responses (115).”
BackgroundDoes Tuberculosis Increase HIV Load?
Day, J. H., Grant, A. D., Fielding, K., Morris, L., Moloi, V., Charalambous, S., Puren, A. J., Chaisson, R. E., Cock, K. M. D., Hayes, R., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/424851 · Cited by 77 · cited 1×
“However, there are additional observations that support the hypothesis that TB accelerates the virologic course of HIV (69).”
Result
Research works printed but not linked: 4
- CDC. 1991. Epidemiologic notes and reports of nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons—Florida and New York, 1988-1991. MMWR Morb. Mortal. Wkly. Rep. 40:585–591.
- Desalu O. . 2009. Impact of immunosuppression on radiographic features of HIV related pulmonary tuberculosis among Nigerians. Turk. Thorac. J. 11:112–116.
- 10.1172/JCI200317533 · doi:10.1172/jci200317533 · Paper page
- Meintjes G. . 2009. Randomized placebo-controlled trial of prednisone for the TB immune reconstitution inflammatory syndrome, abstr. 34. Abstr. Conf. Retrovir. Oppor. Infect. 2009, Montreal, Canada.
Cited by
Infectious disease in an era of global change
Baker, R. E., Mahmud, A. S., Miller, I. F., Rajeev, M., Rasambainarivo, F., Rice, B. L., Takahashi, S., Tatem, A. J., Wagner, C. E., Wang, L.-F., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00639-z · Cited by 2,059
Immune evasion and provocation by Mycobacterium tuberculosis
Chandra, P., Grigsby, S. J., & Philips, J. A. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00763-4 · Cited by 614
Ecology and evolution of Mycobacterium tuberculosis
Gagneux, S. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2018.8 · Cited by 599
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
Tobin, D. M., Roca, F. J., Oh, S. F., McFarland, R., Vickery, T. W., Ray, J. P., Ko, D. C., Zou, Y., Bang, N. D., Chau, T. T. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.023 · Cited by 580
“Similarly, a range of nongenetic immunosuppression—Human ImmunodeficiencyVirus (HIV) infection, TNF-blocking and glucocorticoid treatments—increases susceptibility to TB (Kwan and Ernst, 2011; Lawn and Zumla, 2011).”
BackgroundThe immunological life cycle of tuberculosis
Ernst, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3259 · Cited by 577
Self-citation
Metadata
- Authors
- Kwan, C. K., & Ernst, J. D.
- Affiliations
- New York University (US)
- ORCID
- Ernst, Joel D.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2011-04
- Volume
- 24
- Issue
- 2
- Pages
- 351-376
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC3122491
- OpenAlex
- W2137617609
- Cited by
- 720
- References
- 271
- Citations by year
- 2026: 31 · 2025: 42 · 2024: 40 · 2023: 64 · 2022: 55 · 2021: 51 · 2020: 66 · 2019: 43 · 2018: 59 · 2017: 53 · 2016: 47 · 2015: 45 · 2014: 40 · 2013: 34 · 2012: 46
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI090928, R01AI084041, R01AI051242)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Keywords
- HIV, tuberculosis, syndemic, HIV/TB coinfection, tuberculosis elimination, disease burden, tuberculosis diagnosis, tuberculosis treatment, tuberculosis prevention, multidisciplinary approach
- MeSH terms
- Communicable Disease Control, Humans, Tuberculosis, HIV Infections, Comorbidity, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.